OTC · Medical - Diagnostics & Research

Medivolve Inc. (MEDVF) Stock

$0.00 OTC: MEDVF Healthcare

Medivolve Inc. is a primary investment firm headquartered in Toronto, Canada.

Valuation

MetricValue
Price$0.00
Market Cap$2702
P/E Ratio-0.21
P/B Ratio-0.05
P/S Ratio0.00
EPS (TTM)$-0.61
52-Week High$0.00
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE100.00%
ROA-800.00%
ROCE22.57%
Gross Margin-300.00%
Operating Margin-400.00%
Net Margin-1600.00%
Debt/Equity-0.12
Current Ratio0.06

Annual Financials (USD)

Metric20192020202120222023
Revenue$0$11.0M$87.0M$1.0M$1.0M
Operating Profit$-3.0M$-24.0M$0$-14.0M$-4.0M
Net Profit$-3.0M$-38.0M$-7.0M$-18.0M$-16.0M
EPS$-1.19$-5.66$-0.34$-0.68$-0.61
Op Margin1694.7%-230.8%-0.1%-1044.1%-521.5%

Balance Sheet (USD)

Metric20192020202120222023
Total Assets$2.0M$19.0M$59.0M$19.0M$2.0M
Total Liabilities$0$29.0M$41.0M$18.0M$18.0M
Cash$0$1.0M$0$4.0M$1.0M
Borrowings$0$20.0M$2.0M$2.0M$2.0M

Cash Flow (USD)

Metric20192020202120222023
Operating Cash Flow$-4.0M$-11.0M$-9.0M$6.0M$-3.0M
Investing Cash Flow$-1.0M$-9.0M$-1.0M$0$0
Financing Cash Flow$0$0$0$-1.0M$-1.0M
Net Cash Flow$-4.0M$1.0M$-1.0M$4.0M$-3.0M
Free Cash Flow$-4.0M$-15.0M$-9.0M$6.0M$-3.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-0.61
FCF Yield-386.51%
Quick Ratio0.08
Interest Coverage—
Return 1Y-95.00%
Return 3Y-99.72%
Return 5Y—

Ownership

Insiders Held4.22%
Institutions Held0.00%
Institutions Float Held0.00%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BIOIFBiome Grow Inc. $0.00 — -0.01 $56208 0.00%
CBGLCannabis Global Inc. $0.00 — -3.40 $56821 0.00%
CEOSCeCors, Inc. $0.01 -14.08% 0.67 $1.91M 0.00%
IMMBImmunotech Laboratories, Inc. $0.00 — -0.22 $114993 0.00%
INSDInstadose Pharma Corp. $0.00 — -0.02 $53193 0.00%

About Medivolve Inc.

Medivolve Inc. is a primary investment firm headquartered in Toronto, Canada. Established in 2005, this company, formerly known as QuestCap Inc., channels its investments predominantly into healthcare technology, industrial enterprises, and information technology.

Medivolve Inc. (MEDVF) stock trades at $0.00 with a market capitalization of $2702. The stock is valued at a negative price-to-earnings (P/E) ratio of -0.21, reflecting a net loss over the last twelve months, a negative price-to-book of -0.05, reflecting negative shareholders' equity, price-to-sales of 0.00.

On profitability, Medivolve Inc. generates a return on equity (ROE) of 100.00% (not meaningful, as shareholders' equity is negative), return on capital employed of 22.57%, an operating margin of -400.00%, a net profit margin of -1600.00%.

Official website: www.medivolve.ca

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.